Fernando Antônio Fantini
Universidade Federal de Minas Gerais
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Fernando Antônio Fantini.
European Journal of Cardio-Thoracic Surgery | 2000
Mário O Vrandecic; Fernando Antônio Fantini; Bayard Gontijo Filho; Ozanan César de Oliveira; Idail Martins da Costa Júnior; Erika Correa Vrandecic
OBJECTIVE The study was designed to compare hemodynamic performance, structural failure and survival of patients undergoing aortic valve replacement (AVR) with a composite aortic stented or stentless porcine bioprosthesis. METHODS From January 1990 to June 1999, the clinical data of 725 patients undergoing AVR with stented porcine aortic bioprosthesis were reviewed. We defined two groups of patients with similar clinical characteristics: 202 patients receiving aortic stented and 205 patients stentless valves. The two patients groups were similar in age, sex, valve lesion, valve size, preoperative New York Heart Association (NYHA) class status and follow-up. RESULTS The number of patients available for follow-up, excluding hospital and late mortality, reoperations and patients lost to follow-up, was 157 for the stented and 175 for the stentless group. There was a higher incidence of rheumatic heart disease in the stented (59%) vs. stentless group (44%), (P=0.003). Fewer patients had prior aortic bioprosthetic dysfunction in the stented (7.6%) compared to the stentless group (25%) (P<0.001). The mean intensive care unit stay, hospital mortality and late mortality were similar (P, NS). The total complication rate was higher in the stented (12%) than the stentless (3.4%)(P=0.005). Valve related death was higher in the stented (2.5%) than the stentless (0%) (P=0. 049). Postoperatively, the aortic effective orifice area (AEOA) was larger (P<0.001) and the transvalvular peak and mean gradients were lower in the stentless group (P<0.001). The leaflet tissue degeneration analysis was 8.0% in patients at risk for stented and 0. 6% for stentless (P=0.001). Actuarial analysis disclosed no statistical difference in patient survival between groups (P=0.18). Reoperations were less frequent in the stentless group (P=0.010). CONCLUSIONS Hemodynamic benefits in the stentless group were evident and expressed by larger AEOA, lower gradients, better left ventricular remodeling with significant decrease of the left ventricular mass. Lower complication rates, lower reoperation rates, less leaflet tissue degeneration, and lower valve related mortality rates were seen in the stentless group. A controlled clinical comparison trial with longer follow-up will be required to confirm these clinical and hemodynamic benefits.
Brazilian Journal of Cardiovascular Surgery | 2009
Fernando Antônio Fantini; Bayard Gontijo; Cristiane Martins; Roberto Max Lopes; Erika Correa Vrandecic; Eugênio Goulart; Luiz Lazarini; Leonardo Ferber; Ektor Vrandecic; Mário O Vrandecic
OBJECTIVES Recent experimental flow studies based on angiography and magnetic resonance have shown that total cavopulmonary anastomosis (TCPA) is a valid concept for surgical treatment of many congenital heart defects, but there is not agreement of the best surgical arrangement. Our purpose is to analyze the immediate results with three different techniques of TCPA. METHODS We sought to analyze retrospectively all TCPA realized from January 2005 to July 2008; there were 40 patients, all with previous Glenn anastomosis, with mean age of 6.4 +/- 3.2 years. Three different techniques were employed: Group 1 (G1) lateral tunnel, Group 2 (G2) extracardiac conduits, Group 3 (G3) intracardiac conduit directed to the left pulmonary artery. All patients had a fenestration done. RESULTS G1 had 11 patients, G2 10 patients and G3 19 patients. Preoperative data were similar in the 3 groups (P>0.05). Surgical mortality was higher in Groups 1 and 2 (9.1% and 10%) compared to Group 3 (0%) but there was no statistical significance (P=0.3841). Pleural effusion was absent in Group 3 (0%), which was statistically significant in relation to the other groups (P=0.0128). The hospitalization time was also significantly lower in G3 (8 days) in relation to G1 (18 days) and G2 (13 days) (P=0.0164). CONCLUSION Intracardiac TCPA was associated with lower postoperative morbidity and is currently our preferred technique.
The Annals of Thoracic Surgery | 1998
Mário O Vrandecic; Fernando Antônio Fantini; Bayard Gontijo; Cristiane Martins; Erika Correa Vrandecic
BACKGROUND AND OBJECTIVES We assessed the long-term outcome of a glutaraldehyde-preserved bovine pericardial conduit containing a stentless composite porcine aortic valve. METHODS Between November 1985 and May 1995, 33 stentless porcine valves attached to bovine pericardial conduits were used in 33 patients with complex congenital cardiac malformations. These patients required a conduit between the right ventricle and the pulmonary artery because of an absent or inadequate pulmonic artery. All patients were approached by midsternotomy. One patient with pulmonic atresia and an interventricular septal defect required left thoracotomy for ligation of collaterals. RESULTS Of the initial 33 patients, clinical follow-up was performed in 23 discharged patients (70%) for 1.7 to 10.5 years. The echo-Doppler analysis performed in each of the 23 followed patients showed excellent conduit and valve function in all but 4 patients, in whom a valve gradient of 60 mm Hg was noted. There was no tissue structural failure noticed in this study. CONCLUSIONS The SJM Biocor (Belo Horizonte, Brazil) bovine pericardial stentless valved conduit performed well as a substitute for the right ventricle to pulmonary artery connection.
The Annals of Thoracic Surgery | 1995
Mário O Vrandecic; Fernando Antônio Fantini; Bayard Gontijo; Ozanam Oliveira; Idail Costa Martins Jr; Marcelo H.C. Oliveira; Sandra O. S Avelar; Erika Correa Vrandecic; Ektor Vrandecic
The new stentless porcine mitral valve was developed to serve as an anatomically correct substitute for a diseased mitral valve. Extensive acute animal experimentation was performed, and from this the logical sequence for selecting the correct valve size and the specific technique for implanting it were determined. The following are the major steps to successfully implant a mitral stentless valve: First, mitral valve complex analysis must be done to determine the correct procedure to be performed and the feasibility of using the stentless mitral valve. Second, the correct size of stentless mitral valve must be chosen. Third, the papillary muscle anatomy must be assessed to determine the site and number of sutures necessary for securely holding the new origin of the new chordae. Fourth, the papillary muscle sutures must be anchored to the free pericardial edge of the new chordal origin. Fifth, the chordal alignment with both trigonal areas must be perfect. Sixth, the annulus may be sutured using either continuous or interrupted sutures. Perioperative echocardiography, preferably transesophageal echocardiography, should be done in every patient. Although reoperation was necessary in 5 patients (non-valve-related), the results in 74 patients (3 early and 3 late non-valve-related deaths excluded) followed up for at most 26 months (mean, 14 months) have been excellent. The quality of the results obtained in this initial clinical trial has reinforced our current preference for this valve in patients requiring mitral valve replacement. Longer follow-up is required to confirm that these good results continue.
Brazilian Journal of Cardiovascular Surgery | 2004
Fernando Antônio Fantini; Bayard Gontijo Filho; Cristiane Martins; Roberto Max Lopes; Eliane Heiden; Ektor Vrandecic; Mário O Vrandecic
OBJETIVO: Apresentar os resultados do tratamento da sindrome de hipoplasia do coracao esquerdo (SHCE) com tecnica de Norwood modificada, na qual somente sao usados tecidos autologos para a reconstrucao do arco aortico. METODO: De janeiro a dezembro de 2002, cinco recem-nascidos com idade variando de dois a nove dias (media 5,0 dias) foram submetidos a operacao de Norwood modificada. O diâmetro da aorta ascendente variou de 5 a 8 mm (media 6,2 mm). Foi empregada tecnica na qual o arco aortico e seus ramos foram amplamente dissecados, permitindo a reconstrucao de um novo arco aortico tendo a arteria pulmonar como via de saida, e com a utilizacao exclusiva de tecidos do proprio paciente. Anastomose sistemico-pulmonar com politetrafluoretileno expandido de 3,0 mm foi utilizada em tres pacientes e de 3,5 mm em dois pacientes. Todos foram operados com parada cardiocirculatoria total. RESULTADOS: O tempo de parada cardiocirculatoria variou de 41 a 60 minutos (media 52,8 minutos). Todas as criancas sobreviveram ao ato operatorio e foram encaminhadas para a unidade de terapia intensiva com o esterno aberto. Ocorreu um obito no 9: dia de pos-operatorio por sepse, o que resultou numa taxa de sobrevivencia imediata de 80%. Ocorreu um obito tardio por pneumonia de aspiracao aos dois meses. Uma crianca foi submetida ao segundo estagio da operacao (cavo pulmonar) e encontra-se bem. Duas criancas estao em acompanhamento aguardando o proximo estagio. Em nenhuma delas existem evidencias de obstrucao do novo arco aortico. CONCLUSAO: A tecnica de Norwood modificada mostrou-se eficaz e com risco cirurgico aceitavel para o tratamento da SHCE, sem evidencias de obstrucao do arco aortico reconstruido.
Revista Brasileira De Cirurgia Cardiovascular | 2007
Bayard Gontijo Filho; Fernando Antônio Fantini; Roberto Max Lopes; Cristiane Martins; Eliana Heyden; Erika Correa Vrandecic; Mario Osvaldo Vrandecic Peredo
Objective: Our results on the transposition of the great arteries with aortic arch obstruction were analyzed to establish our present protocol.
Revista Brasileira De Cirurgia Cardiovascular | 2001
Bayard Gontijo Filho; Fernando Antônio Fantini; Harold M. Lora; Cristiane Martins; Roberto Max Lopes; Eliane Hayden; Mário O Vrandecic
INTRODUCTION: We describe our experience with Jatenes operation in the surgical treatment of transposition of great arteries (TGA) where pulmonary artery reconstruction was performed with two autologous pericardial patches in order to spare the maximum amount of native aortic tissue. MATERIAL AND METHODS: There were 52 children (38 simple TGA, 14 TGA + VSD) and their age ranged from 3 days to 17 months. Body weight ranged from 2.400 to 7.400 kg (m=3.377 kg). All patients were operated under moderate hypothermia with a single infusion of blood cardioplegia. Average extracorporeal circulation time was 110.6 min and average aortic cross-clamping time was 72.5 min. RESULTS: There were 3 (5.8%) early deaths caused by pulmonary infection in 2 of them and by obstruction of the endotracheal tube in 1. There were 2 late deaths; one in a reoperation of severe coronary ostial stenosis (6 months p.o.) and another owing to pneumonia (1 year p.o.). Late echocardiography was performed in 20 children who were operated in the neonatal period and had a minimum of 5 months follow-up (m=12.7). Supravalvular pulmonary stenosis was found in only 1 (5%) patient and results were consistent with an uniform pulmonary artery development. CONCLUSION: Reconstruction of the pulmonary artery in Jatenes operation for TGA should be carried out with maximal preservation of the native aortic tissue.
European Journal of Cardio-Thoracic Surgery | 1997
Mário O Vrandecic; Bayard Gontijo; Fernando Antônio Fantini; I. Martins; M. H. Oliveira; S. S. Avelar; Ozanan César de Oliveira; Erika Correa Vrandecic
OBJECTIVES Time testing is essential with any valvular procedure, especially when a new concept is introduced such as the mitral stentless valve. Our purpose is to evaluate the results obtained over 4 years with this operation, particularly to attest the impact of preservation of annulo ventricular continuity on the long term results of these patients. METHODS From March 1992 to August 1996, 120 patients had their mitral valves replaced with a porcine stentless mitral valve. The observation period was 54 months with total patients follow-up of 3424 months with a mean of 28.5 months. The age ranged from 11 to 72 years (mean 35.22 +/- 14.98). There were 73 females (60.8%) and 47 males (39.2%). The predominant etiology was rheumatic heart disease. Associated procedures were performed in 12 patients (10%), and the great majority of the patients were in functional class III and IV (NYHA). RESULTS Hospital mortality occurred in seven patients (5.83%) non valve related except for one early case of endocarditis. Early reoperation related to technical failure were necessary in 4 patients without mortality. Follow-up was accomplished in 101 patients and ranged from 2 to 54 months. Late reoperations were required in 16 patients (nine due to mitral insufficiency, five because of endocarditis and two for mitral stenosis). Most reoperations were related to technical failure. Among the 82 patients presently in control, 72 showed a competent mitral stentless valve, eight with stable mild mitral regurgitation and in two a decreased mitral orifice. Hemodynamic performance of the valve has been excellent in this group, particularly in patients with left ventricular dysfunction. CONCLUSION Although technical complexity remains the main cause of reoperations with this valve, experience has shown that it not only provides preservation of the left ventricular function but also promised significant increase of the ejection fraction in patients with poor left ventricular function.
Revista Brasileira De Cirurgia Cardiovascular | 1995
Fernando Antônio Fantini; Bayard Gontijo Filho; Roberto Max Lopes; Marcelo Frederico de Castro; Arturo Barrientos; João Alfredo de Paula e Silva; Juscelino Teixeira Barbosa; Heberth César Miotto; Tereza Lúcia de Melo Masci; Cristiane Martins; Mário O Vrandecic
In order to evaluate the effects of pulsatile flow in the pulmonary artery of patients undergoing bidirectional cavopulmonary shunts (BCS), we reviewed the data of 36 patients operated upon from October 1990 to July 1994. Age at operation ranged from 11 months to 14 years (mean 4.4 ± 3.4 years) and diagnoses were as follows: tricuspid atresia (18), single ventricle (16), mitral atresia (1) and pulmonary atresia with intact ventricular septum (1). A total of 19 (52.8%) patients had a prior palliative operation done. Cardiopulmonary bypass was used in every case, with mild hypothermia in 11 cases and profound hypothermia and circulatory arrest in the remaining. The surgical technique was an anastomosis between the superior vena cava and the ipsilateral pulmonary artery in an end-to-side fashion. The main pulmonary artery was ligated only if the mean pressure taken at the site of the anastomosis was higher than 15 mmHg but in 2 recent cases with a very high mean pulmonary pressure, the main pulmonary artery was banded, adjusting the pressure to the desirable levels. The overall hospital survival was 91.7% (33 patients). One patient required a systemic to pulmonary shunt due to persistent low arterial oxygen saturation, 7 days after the BCS. Twenty-eight patients were followed for a mean of 1.8 ± 1.2 years (3 months to 4.1 years) and were divided in 2 groups: A-18 patients without pulsatile flow in the pulmonary artery, and B-10 patients with pulsatile flow. In Group B, the mean arterial saturation has ranged from 80% to 90% (mean 86 ± 3.8%) and is significantly higher than in Group A (68 to 85%, mean, 77.6 ± 5.5) (p<0.001). Two patients of Group A are in NYHA functional class III, whereas all patients of Group B are in class I or II (p=0.05). There was one late death and one patient required a subsequent Fontan procedure, both of Group A. Thus, the presence of pulsatile flow in the pulmonary artery improved the arterial oxigen saturation and exercise tolerance in patients submitted to a cavopulmonary shunt, without adverse effects on pulmonary circulation.
Revista Brasileira De Cirurgia Cardiovascular | 1988
Mário Osvaldo Vrandecic; Bayard Gontijo Filho; João Alfredo de Paula e Silva; Fernando Antônio Fantini; Juscelino Teixeira Barbosa; Márcio Campos de Säo José; Carlos Álvaro dos Santos Pinto; Gilberto Lino Vieira; Homero Geraldo de Oliveira; Renato R Rabelo; Sebastião Correa Rabello; Alexandre Visconti Brick; Eduardo Peredo; Adelson A Pedrosa; Antônio Luiz de O. A. Sobrinho; Maurício Resende Barbosa; Heberth César Miotto; Maria Aparecida Braga; Marco Antonio Salum; Júnia F Braga; Guilherme H Moreira; Osvald Hely Moreira; Carlos Alberto de Oliveira; Flávio Justo Maciel
No periodo de marco de 1981 a marco de 1988, foram implantadas 2324 bioproteses, em 2016 pacientes, em 5 Centros do Estado de Minas Gerais. Este estudo inclui somente a analise dos pacientes submetidos a troca valvar aortica (n = 603) e mitral ( n = 1110), isoladamente. Neste grupo (n = 1713), a mortalidade hospitalar foi de 104 pacientes (6,1%). Dos 1609 pacientes que receberam alta do hospital, conseguimos o seguimento de 1101 pacientes (64,3). Esta analise corresponde a um periodo de 1 a 84 meses, com media de 48 meses e com um seguimento cumulativo de: aorticas (n= 385) = 1230 pacientes/ano; mitrais (n = 716) = 3018 pacientes/ano. Foram registradas 102 complicacoes tardias em 716 pacientes mitrais (14,24%) e 51 complicacoes no grupo aortico (13,2%). Com relacao a faixa etaria, encontramos 220 pacientes menores de 20 anos (mitrais = 176/aorticos = 44) e, neste subgrupo, as disfuncoes valvares incidiram em 43% dos pacientes mitrais e em 29% dos pacientes aorticos. A endocardite protetica foi mais encontrada nos aorticos (45%) do que nos mitrais (29,7%). Dos 1101 pacientes, 62 foram reoperados, com mortalidade hospitalar de 12,6%. A reoperacao por disfuncao valvar foi mais frequente no grupo mitral com idade inferior a 20 anos. A curva atuarial livre de mortalidade relacionada a bioprotese foi de 97,1% (32/1101 pacientes). No grupo aortico, 96,9% estiveram livres de disfuncao valvar ao final de 7 anos, enquanto que, no grupo mitral, este indice foi de 95,2%. Nos pacientes menores de 20 anos do grupo mitral, encontramos o maior indice de falencia valvar (85,3% livre apos 7 anos). Ao final deste estudo, a maior parte destes pacientes encontrava-se em classe funcional I e II. Embora a incidencia de reoperacao seja expressiva, esta e aceitavel, tendo em vista que as bioproteses oferecem uma alternativa mais segura do que as proteses mecânicas, durante este mesmo periodo do seguimento. A analise destes resultados sugere a continuacao de pesquisas que tornem possivel a fabricacao de um substituto valvar ideal. Todavia, estes resultados comparam-se, de modo favoravel, a resultados com bioproteses semelhantes da literatura mundial.